openPR Logo

Press Releases from DelveInsight Business Research (5349 total)

Bipolar Disorder Clinical Trials Assessment 2024: FDA Approvals, Drugs, Clinical …

(Albany, USA) DelveInsight's, "Bipolar Disorder Pipeline Insight 2024" report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Bipolar Disorder pipeline landscape.

HER2-Positive Breast Cancer Clinical Trials Assessment 2024: FDA Approvals, Drug …

(Albany, USA) DelveInsight's, "HER2 Positive Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in HER2 Positive Breast

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Clinical Trials Assessment …

(Albany, USA) DelveInsight's, "Human Immunodeficiency Virus Type 1 (HIV-1) Infection Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in

Cardiovascular Calcification Pipeline Drugs Analysis Report, 2024 Updates: FDA A …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Cardiovascular Calcification pipeline constitutes 6+ key companies continuously working towards developing 6+ Cardiovascular Calcification

Eosinophilic Esophagitis Pipeline and Clinical Trials Assessment, 2024 Updates: …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Eosinophilic Esophagitis pipeline constitutes 18+ key companies continuously working towards developing 20+ Eosinophilic Esophagitis

Malt Lymphoma Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, E …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Malt Lymphoma pipeline constitutes 10+ key companies continuously working towards developing 12+ Malt Lymphoma

Postoperative Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Postoperative Pain pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain

Acute Myeloid Leukemia Pipeline Forecast 2024: FDA Approvals, Therapies, and Lea …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Myeloid Leukemia pipeline constitutes 110+ key companies continuously working towards developing 120+ Acute

Diabetes Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Clin …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetes pipeline constitutes 200+ key companies continuously working towards developing 200+ Diabetes treatment therapies,

Focal Segmental Glomerulosclerosis Pipeline 2024: Clinical Trials Assessment, FD …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Focal Segmental Glomerulosclerosis pipeline constitutes 15+ key companies continuously working towards developing 18+ Focal

Nasal Polyposis Market 2034: Epidemiology Trends, Innovative Therapies, Regulato …

DelveInsight's "Nasal Polyposis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Nasal Polyposis, historical and forecasted epidemiology as well as

Antibody-mediated Rejection Market is Predicted to Exhibit Remarkable Growth Dur …

DelveInsight's "Antibody-mediated Rejection Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Antibody-mediated Rejection, historical and forecasted epidemiology as well as

Asthma Clinical Trials Assessment 2024: FDA Approvals, Drugs, Clinical Trials, T …

(Albany, USA) DelveInsight's, "Asthma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in the Asthma pipeline landscape. It covers

Anti-CD20 Antibody Clinical Trials Assessment 2024: FDA Approvals, Drugs, Clinic …

DelveInsight's, "Anti-CD20 Antibody Pipeline Insight 2024" report provides comprehensive insights about 20+ Anti-CD20 Antibody companies and 20+ pipeline drugs in Anti-CD20 Antibody pipeline landscape. It

Advanced Endometrial Cancer Clinical Trials Assessment 2024: FDA Approvals, Drug …

(Albany, USA) DelveInsight's, "Advanced Endometrial Cancer Pipeline Insight 2024" report provides comprehensive insights about 25+ Advanced Endometrial Cancer companies and 25+ pipeline drugs in the

Advanced Merkel Cell Carcinoma Clinical Trials Assessment 2024: FDA Approvals, D …

DelveInsight's, "Advanced Merkel cell carcinoma Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Advanced Merkel cell carcinoma pipeline

Non Muscle Invasive Bladder Cancer (NMIBC) Clinical Trials Assessment 2024: FDA …

DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 20+ Non Muscle Invasive Bladder Cancer companies and 25+ pipeline drugs

Vascular Dementia Drugs Market 2032: Clinical Trials, Therapies, FDA Approvals, …

(Albany, USA) DelveInsight's "Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as

Limb Girdle Muscular Dystrophy Clinical Trials Assessment 2024: FDA Approvals, D …

(Albany, USA) Limb Girdle Muscular Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 25+ Limb Girdle Muscular Dystrophy treatment therapies, analysis of Clinical

RIPK1 Inhibitor Clinical Trials Analysis 2024: FDA Approvals, Therapies, Pipelin …

RIPK1 Inhibitor pipeline constitutes 10+ key companies continuously working towards developing 12+ RIPK1 Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route

Atypical Teratoid Rhabdoid Tumors Clinical Trials Analysis 2024: Clinical Trials …

(Albany, USA) Atypical Teratoid Rhabdoid Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Atypical Teratoid Rhabdoid Tumors treatment therapies, analysis of Clinical

Ewing Sarcoma Clinical Trials Assessment 2024: Pipeline, FDA Approvals, Clinical …

(Albany, USA) Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of

Bladder Pain Syndrome Market Forecast 2032: Prevalence, FDA Approvals, Therapies …

(Albany, USA) DelveInsight's "Bladder Pain Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bladder Pain Syndrome, historical and forecasted

Benign Breast Disease and Early Breast Cancer Treatment Market 2032: FDA Approva …

(Albany, USA) DelveInsight's "Benign Breast Disease and Early Breast Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Benign Breast

Biliary Atresia Market Forecast 2032: Epidemiology, FDA Approvals, Therapies, Cl …

The Biliary Atresia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Biliary

Becker Muscular Dystrophy Market Forecast 2032: Epidemiology, FDA Approvals, The …

(Albany, USA) The Becker Muscular Dystrophy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching

Basal Cell Carcinoma Market Forecast 2032: Epidemiology, FDA Approvals, Therapie …

DelveInsight's "Basal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Basal Cell Carcinoma, historical and forecasted epidemiology as

Migraine Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, and Clinic …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies,

Head and Neck cancer Pipeline Forecast 2024: FDA Approvals, Therapies, and Leadi …

Head and Neck cancer pipeline constitutes 7+ key companies continuously working towards developing 8+ Head and Neck cancer treatment therapies, analysis of Clinical Trials, Therapies,

Chronic Kidney Disease Pipeline Update 2024: FDA Approvals, Therapeutic Advancem …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Kidney Disease pipeline constitutes 76+ key companies continuously working towards developing 80+ Chronic

Non-Hodgkin Lymphoma Pipeline 2024: Clinical Trials Assessment, FDA Approvals, T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 200+ key companies continuously working towards developing 220 + Non-Hodgkin

Generalized Myasthenia Gravis Market Forecasted to Surge in Coming Years, 2023-2 …

DelveInsight's "Generalized Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Generalized Myasthenia Gravis, historical and forecasted epidemiology as

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Clinical Trial …

(Albany, United States) "Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and

FAK Inhibitor Market Poised for Significant Growth by 2034, Asserts DelveInsight …

(New York, USA) DelveInsight's FAK Inhibitors Competitive Landscape report delivers an in-depth understanding of the FAK inhibitors and the FAK inhibitors market trends in the

Diabetic Retinopathy Treatment Market 2032: Clinical trial, FDA Approvals, Preva …

(Albany, USA) DelveInsight's "Diabetic Retinopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Diabetic Retinopathy, historical and forecasted epidemiology as well

Opioid Kappa Receptor Agonists Market Poised for Significant Growth by 2034, Ass …

(Albany, USA) The Opioid Kappa Receptor Agonists market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the

OX40 Ligand Inhibitors Market is Poised to boom by 2032, Assesses Delveinsight | …

(Albany, USA) The OX40 Ligand Inhibitors market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM.

Hepatic Encephalopathy Market Forecast by 2032: Epidemiology Analysis, Emerging …

DelveInsight's "Hepatic Encephalopathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hepatic Encephalopathy, historical and forecasted epidemiology as well as

Giant Cell Arteritis Market 2032: Epidemiology Insights, Pipeline Updates, Regul …

The Giant Cell Arteritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage

RIPK1 Inhibitor Pipeline and Clinical Trials Assessment 2024: FDA Approvals, The …

RIPK1 Inhibitor pipeline constitutes 10+ key companies continuously working towards developing 12+ RIPK1 Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route

Generalized Anxiety Disorder Pipeline Drugs Analysis Report, 2024: FDA Approvals …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized

Intrahepatic Cholangiocarcinoma Pipeline and Clinical Trials Assessment 2024: FD …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma

Epidermolysis Bullosa Market Forecast 2034: Clinical Trials, Epidemiology, FDA A …

DelveInsight's "Epidermolysis Bullosa Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Epidermolysis Bullosa, historical and forecasted epidemiology as

Degenerative Disk Disease Market to Reach New Heights in Growth by 2032, DelveIn …

DelveInsight's "Degenerative Disk Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Degenerative Disk Disease, historical and forecasted epidemiology as

Hepatocellular Carcinoma Market Growth to Accelerate in Forecast Period (2023-20 …

DelveInsight's "Hepatocellular Carcinoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hepatocellular Carcinoma, historical and forecasted epidemiology as well as

Malignant Pleural Mesothelioma Market Predicted to See Upsurge Through 2032, Hig …

DelveInsight's "Malignant Pleural Mesothelioma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Malignant Pleural Mesothelioma, historical and forecasted epidemiology as

Vasculitis Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Compani …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Vasculitis pipeline constitutes 20+ key companies continuously working towards developing 30+ Vasculitis treatment therapies,

Spasticity Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spasticity pipeline constitutes 20+ key companies continuously working towards developing 20+ Spasticity treatment therapies,

APAC Cervical Cancer Market Poised for Unprecedented Growth in the Next Decade b …

DelveInsight's "Cervical Cancer Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report delivers an in-depth understanding of Cervical Cancer, historical and forecasted epidemiology

Biliary Tract Cancer Market Poised for Remarkable Growth in APAC Over the Next D …

(Albany, USA) DelveInsight's "Biliary Tract Cancer Market Size, Patient Pool Analysis, and Market Forecast APAC, 2034" report delivers an in-depth understanding of Biliary Tract Cancer,

Go To Page:    31 32 33 34 35 36 37 38 39 40